🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

RecruitingNAAges 19 Years - anyAllWonju Severance Christian Hospital
NCT06250712 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

HELP-A is a prospective, randomized, open-label, multicenter comparative-effectiveness trial comparing two ambulatory electrocardiographic monitoring strategies in adults with palpitations or dizziness and a nondiagnostic 12-lead ECG. A total of 588 participants are randomized 1:1 to 30-day intermittent handheld 6-lead ECG monitoring (Hativ) or up to 7 days of continuous single-lead patch ECG monitoring (Memo Patch). The primary endpoint is clinically informative symptom-rhythm correlation established with the initially assigned device by the 1-month follow-up visit. Participants without a symptom-rhythm correlation who remain symptomatic may undergo optional sequential monitoring with the alternative device after primary endpoint ascertainment. Clinical outcomes, arrhythmia-directed interventions, healthcare resource utilization, costs, and adverse events are assessed through 3 months.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 19 years or older. * Palpitations or dizziness not explained by the presenting 12-lead ECG. * A clinical indication for additional ambulatory ECG monitoring. * Ownership of and ability to use a compatible smartphone. * Ability to provide written informed consent and comply with study procedures Exclusion Criteria: * Physical disability or another condition that prevents appropriate use of the handheld ECG device. * Presence of a cardiac implantable electronic device or ventricular assist device. * Inability to read or understand the informed consent document. * Any other condition that, in the investigator's judgment, makes participation in the study inappropriate.
💊

What it tests

  • Memo Patch continuous ECG
  • Hativ handheld ECG
📍

Where

4 sites
Chonnam National University Hospital
Gwangju, South Korea
Wonju Severance Christian Hospital
Wŏnju, South Korea
Hallym University Dongtan Sacred Heart Hospital
Gyeonggi-do, South Korea
Korea University Anam Hospital
Seoul, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy